US sales for Mer­ck KGaA’s Baven­cio im­pact­ed by Pad­cev/Keytru­da mo­men­tum in blad­der can­cer

Fol­low­ing the stand­ing ova­tion for Seagen and Astel­las’ Pad­cev in com­bi­na­tion with Mer­ck’s Keytru­da at last year’s ES­MO Con­gress, Mer­ck KGaA is see­ing US sales …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER